NCT03114306

Brief Summary

Mobilisation following knee arthroplasty is an important aspect to achieve early and enhanced recovery after surgery and sufficient joint function. Analgesia is a crucial therapeutic element in this context. This RCT evaluates two analgetic regimens for patients undergoing primary total knee-replacement to assess impact on postoperative recovery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 27, 2017

Completed
9 days until next milestone

Study Start

First participant enrolled

April 5, 2017

Completed
9 days until next milestone

First Posted

Study publicly available on registry

April 14, 2017

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2017

Completed
Last Updated

February 13, 2024

Status Verified

February 1, 2024

Enrollment Period

5 months

First QC Date

March 27, 2017

Last Update Submit

February 11, 2024

Conditions

Keywords

ERASpainknee arthroplastyjoint painregional anaesthesia

Outcome Measures

Primary Outcomes (1)

  • time to first mobilisation (standing)

    time from end of surgery until patients is able to stand

    up to 48h postoperatively

Secondary Outcomes (8)

  • patients satisfaction (11-point likert scale)

    up to 7 days postoperatively

  • time to first mobilisation (walking)

    up to 7 days postoperatively

  • complications

    up to 7 days postoperatively

  • time to achieve full joint mobility

    up to 7 days postoperatively

  • pain intensity of patients (11-point likert visual analogue scale) measured 3 times daily (mean)

    up to 7 days postoperatively

  • +3 more secondary outcomes

Study Arms (2)

local infiltration analgesia

EXPERIMENTAL

Patient receive an infiltration of local anaesthetics around the knee to achieve maximal distal block of nerve fibres. Infiltration is performed directly after knee replacement and during weaning of general anaesthesia.

Procedure: local infiltration analgesia

Regional anaesthesia

ACTIVE COMPARATOR

Patients receive a combined anaesthesia with a regional-anaesthesiological catheter placed close to the distal Nervus saphenus and a single shot anaesthesia of Nervus ischiadicus using local anaesthetics (regional-anaesthesiological catheter analgesia).

Procedure: regional-anaesthesiological catheter analgesia

Interventions

Patient receive an infiltration of local anaesthetics around the knee directly after total knee replacement for postoperative pain control.

Also known as: LIA technique
local infiltration analgesia

Patients receive a single shot nerve block of the proximal Nervus ischiadicus and a catheter placed closed to the Nervus saphenus for perioperative pain control using ultrasound guided techniques.

Regional anaesthesia

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients undergoing elective, primary knee joint replacement in combined general anaesthesia

You may not qualify if:

  • heart insufficiency NYHA \>2
  • liver insufficiency \> CHILD B
  • evidence of diabetic polyneuropathy
  • severe adipositas BMI \>40
  • patients \< 18 years
  • pregnancy
  • in case of police custody
  • participation in a paralleled interventional RCT in a time frame of 30 days
  • chronic opioid therapy \>3 months before scheduled surgery
  • allergy against medication required for surgery or anaesthesia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Charité University Berlin (CCM)

Berlin, 13353, Germany

Location

Related Publications (4)

  • Rostlund T, Kehlet H. High-dose local infiltration analgesia after hip and knee replacement--what is it, why does it work, and what are the future challenges? Acta Orthop. 2007 Apr;78(2):159-61. doi: 10.1080/17453670710013627. No abstract available.

    PMID: 17464601BACKGROUND
  • Peters CL, Shirley B, Erickson J. The effect of a new multimodal perioperative anesthetic regimen on postoperative pain, side effects, rehabilitation, and length of hospital stay after total joint arthroplasty. J Arthroplasty. 2006 Sep;21(6 Suppl 2):132-8. doi: 10.1016/j.arth.2006.04.017.

    PMID: 16950075BACKGROUND
  • Kastelik J, Fuchs M, Kramer M, Trauzeddel RF, Ertmer M, von Roth P, Perka C, Kirschbaum SM, Tafelski S, Treskatsch S. Local infiltration anaesthesia versus sciatic nerve and adductor canal block for fast-track knee arthroplasty: A randomised controlled clinical trial. Eur J Anaesthesiol. 2019 Apr;36(4):255-263. doi: 10.1097/EJA.0000000000000929.

  • Borck M, Wandrey JD, Hoft M, Kastelik J, Perka C, Tafelski S, Treskatsch S. Local infiltration analgesia versus peripheral nerve block anaesthesia in total knee arthroplasty: a pharmaco-economic comparison. BMC Anesthesiol. 2022 Mar 25;22(1):80. doi: 10.1186/s12871-022-01620-w.

MeSH Terms

Conditions

Pain, PostoperativePostoperative ComplicationsPainArthralgia

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsNeurologic ManifestationsSigns and SymptomsJoint DiseasesMusculoskeletal Diseases

Study Officials

  • Sascha Treskatsch, Prof.

    Charite University Berlin, Department of anaesthesia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Investigator and treating physicians are different in this trial, that means, the assessor of primary study endpoint will be blinded regarding group allocation. Patients receive either regional-anaesthesiological catheters preoperatively or are treatet with local infiltration technique perioperatively. For the purpose of this trial is would not be feasable to perform sham regional-anaesthesiological procedures and blinding of the treating physisican will not be possible.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of department

Study Record Dates

First Submitted

March 27, 2017

First Posted

April 14, 2017

Study Start

April 5, 2017

Primary Completion

August 30, 2017

Study Completion

August 30, 2017

Last Updated

February 13, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Individual requests to analyse data are to be evaluated by local data safety authorities

Locations